Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details)

v3.23.1
Stockholders’ Equity (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Mar. 16, 2023
Mar. 01, 2023
Feb. 09, 2023
Jan. 31, 2023
Jan. 26, 2023
Jan. 23, 2023
Jan. 01, 2023
Dec. 31, 2023
Oct. 26, 2022
Mar. 22, 2022
Jan. 29, 2021
Mar. 31, 2023
Dec. 31, 2022
Dec. 31, 2018
Stockholders’ Equity (Details) [Line Items]                            
Common stock, authorized                       116,666,667 116,666,667  
Common stock par value (in Dollars per share)                       $ 0.0001 $ 0.0001  
Common stock, shares issued                       49,108,159 44,108,661  
Common stock, shares outstanding                       44,108,661    
Preferred stock shares                       10,000,000 10,000,000  
Preferred stock, par value (in Dollars per share)                       $ 0.0001 $ 0.0001  
Preferred stock, authorized                       5,000,000 5,000,000  
Certificate of designation series A preferred stock                       5,000,000 5,000,000  
Preferred stock, shares issued                        
Preferred stock, shares outstanding                        
Description of transaction                     On January 29, 2021, the Company filed a shelf Registration Statement on Form S-3 for up to $150,000,000 with the SEC (the “Form S-3”) for shares of its Common Stock; shares of its preferred stock, which the Company may issue in one or more series or classes; debt securities, which the company may issue in one or more series; warrants to purchase its Common Stock, preferred stock or debt securities; and units. The Form S-3 was declared effective by the SEC on February 5, 2021.      
Aggregate amount (in Dollars)                 $ 11,696,000          
ATM agreement description                   the Company, entered into an Equity Distribution Agreement (the “ATM Agreement”) with Oppenheimer. (the “Sales Agent”). Pursuant to the terms of the ATM Agreement, the Company may offer and sell (the “ATM Offering”) from time to time through the Sales Agent, as the Company’s sales agent, up to $50 million of shares of Common Stock, (the “ATM Shares”). Sales of the ATM Shares, if any, may be made in sales deemed to be “at the market offerings” as defined in Rule 415 promulgated under the Securities Act        
Percentage of gross proceeds                   3.00%        
Share of common stock   296,191   1,085,874 3,000,000   4,794              
Warrants exercise price (in Dollars per share)           $ 9.95           $ 7.96    
Warrants outstanding to purchase an aggregate           586,440             1,901,802  
Options term                         7 years 5 months 19 days  
Stock options to purchase common stock description           On January 23, 2023, in connection with the acquisition of Airobotics, the Company granted stock options to purchase 1,064,946 shares of Common Stock, of which 773,244 options were vested and the remaining 291,702 vest monthly through November 13, 2025. The vested options have a weighted average contractual remaining life of approximately 6.08 years, an exercise price ranging from $0.49 to $12.35 per share, resulting in a weighted average exercise price of $5.43 per share, and a grant date fair value ranging from $0 to $1.48 per share. The unvested options have a weighted average contractual remaining life of approximately 7.52 years, an exercise price ranging from $0.49 to $24.70 per share, resulting in a weighted average exercise price of $15.80 per share, and a grant date fair value ranging from $0 to $1.45 per share.            The actual number of shares subject to the award is determined at the end of the performance period and may range from zero to 100% of the target shares granted depending upon the terms of the award.    
Aggregate stock option 1,793,000   317,625                      
Compensation expense related to non-vested options (in Dollars)                       $ 3,527,915    
Weighted-average period                       3 years 2 months 1 day    
Restricted stock units description     On February 9, 2023, the Committee approved the grant of 3,000 restricted stock units to an employee. The restricted stock units vest in two successive equal annual installments with the first vesting date commencing on the first anniversary of the award date and are contingent on continuing employment.                       
Equity Incentive Plan [Member]                            
Stockholders’ Equity (Details) [Line Items]                            
Common stock reserved for issuance                           3,333,334
Warrant [Member]                            
Stockholders’ Equity (Details) [Line Items]                            
Warrants issued                       2,366,092    
Weighted-average contractual remaining life                       6 years 10 days    
Maximum [Member]                            
Stockholders’ Equity (Details) [Line Items]                            
Aggregate offering price (in Dollars)                 50,000,000          
Warrants exercise price (in Dollars per share)           $ 12.35           $ 12.35    
Minimum [Member]                            
Stockholders’ Equity (Details) [Line Items]                            
Aggregate offering price (in Dollars)                 $ 40,000,000          
Warrants exercise price (in Dollars per share)           $ 9.26           $ 0.03    
Stock Option [Member]                            
Stockholders’ Equity (Details) [Line Items]                            
Aggregate stock option 31,250                          
Securities Purchase Agreement [Member] | Warrant [Member]                            
Stockholders’ Equity (Details) [Line Items]                            
Warrants exercise price (in Dollars per share)                         $ 7.63  
Securities Purchase Agreement [Member] | Maximum [Member] | Warrant [Member]                            
Stockholders’ Equity (Details) [Line Items]                            
Warrants exercise price (in Dollars per share)                         7.89  
Securities Purchase Agreement [Member] | Minimum [Member] | Warrant [Member]                            
Stockholders’ Equity (Details) [Line Items]                            
Warrants exercise price (in Dollars per share)                         $ 0.03  
Forecast [Member]                            
Stockholders’ Equity (Details) [Line Items]                            
Stock option vested               6,250            
Vested shares               25,000            
Equity Incentive Plan [Member]                            
Stockholders’ Equity (Details) [Line Items]                            
Common stock reserved for issuance                       6,000,000    
Restricted Stock Units [Member]                            
Stockholders’ Equity (Details) [Line Items]                            
Restricted stock units description     On February 9, 2023, the Committee also approved the grant of 66,000 restricted stock units to two employees. The restricted stock units vest as follows: 20% on September 13, 2023, 40% on January 10, 2024, and 40% on February 21, 2024 and are contingent on continuing employment.